TransMedics Group, Inc. ($TMDX)
Weill David โ Director
Shares
3,571
Price
$0.00
Total Value
$0.00
Nearby Earnings
Feb 24, 2026
EPS:Est: 0.41
Revenue:Est: $155.28M
Feb 26, 2026
EPS:Est: 0.41
Transaction Details
| Insider | Weill David |
|---|---|
| Title | Director |
| Transaction Date | Mar 4, 2026 |
| Expiration Date | Jun 4, 2030 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Stock Option (Right to Buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Mar 6, 2026 |
| Shares Purchased | 3,571 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 1,429 |
| Derivative | Derivative |
| Accession Number | 0001193125-26-097051 |
| Document | View SEC Filing |